ID   RPA1_HUMAN              Reviewed;        1720 AA.
AC   O95602; B7Z7T0; D6W5M0; Q0VG05; Q9UEH0; Q9UFT9;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   10-MAY-2017, entry version 160.
DE   RecName: Full=DNA-directed RNA polymerase I subunit RPA1;
DE            Short=RNA polymerase I subunit A1;
DE            EC=2.7.7.6;
DE   AltName: Full=A190;
DE   AltName: Full=DNA-directed RNA polymerase I largest subunit;
DE   AltName: Full=DNA-directed RNA polymerase I subunit A;
DE   AltName: Full=RNA polymerase I 194 kDa subunit;
DE            Short=RPA194;
GN   Name=POLR1A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT ALA-150.
RA   Wang D., Stetler D.A.;
RL   Submitted (AUG-1995) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ALA-150.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1626-1720.
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   IDENTIFICATION IN THE RNA POL I COMPLEX.
RX   PubMed=16809778; DOI=10.1128/MCB.00230-06;
RA   Panov K.I., Panova T.B., Gadal O., Nishiyama K., Saito T., Russell J.,
RA   Zomerdijk J.C.B.M.;
RT   "RNA polymerase I-specific subunit CAST/hPAF49 has a role in the
RT   activation of transcription by upstream binding factor.";
RL   Mol. Cell. Biol. 26:5436-5448(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1386, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   INTERACTION WITH ERBB2.
RX   PubMed=21555369; DOI=10.1158/0008-5472.CAN-10-3504;
RA   Li L.Y., Chen H., Hsieh Y.H., Wang Y.N., Chu H.J., Chen Y.H.,
RA   Chen H.Y., Chien P.J., Ma H.T., Tsai H.C., Lai C.C., Sher Y.P.,
RA   Lien H.C., Tsai C.H., Hung M.C.;
RT   "Nuclear ErbB2 enhances translation and cell growth by activating
RT   transcription of ribosomal RNA genes.";
RL   Cancer Res. 71:4269-4279(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [13]
RP   INVOLVEMENT IN AFDCIN, AND VARIANTS AFDCIN GLN-593 AND PHE-1299.
RX   PubMed=25913037; DOI=10.1016/j.ajhg.2015.03.011;
RA   Weaver K.N., Watt K.E., Hufnagel R.B., Navajas Acedo J.,
RA   Linscott L.L., Sund K.L., Bender P.L., Koenig R., Lourenco C.M.,
RA   Hehr U., Hopkin R.J., Lohmann D.R., Trainor P.A., Wieczorek D.,
RA   Saal H.M.;
RT   "Acrofacial dysostosis, Cincinnati type, a mandibulofacial dysostosis
RT   syndrome with limb anomalies, is caused by POLR1A dysfunction.";
RL   Am. J. Hum. Genet. 96:765-774(2015).
RN   [14]
RP   INTERACTION WITH DDX11.
RX   PubMed=26089203; DOI=10.1093/hmg/ddv213;
RA   Sun X., Chen H., Deng Z., Hu B., Luo H., Zeng X., Han L., Cai G.,
RA   Ma L.;
RT   "The Warsaw breakage syndrome-related protein DDX11 is required for
RT   ribosomal RNA synthesis and embryonic development.";
RL   Hum. Mol. Genet. 24:4901-4915(2015).
CC   -!- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription
CC       of DNA into RNA using the four ribonucleoside triphosphates as
CC       substrates. Largest and catalytic core component of RNA polymerase
CC       I which synthesizes ribosomal RNA precursors. Forms the polymerase
CC       active center together with the second largest subunit. A single
CC       stranded DNA template strand of the promoter is positioned within
CC       the central active site cleft of Pol I. A bridging helix emanates
CC       from RPA1 and crosses the cleft near the catalytic site and is
CC       thought to promote translocation of Pol I by acting as a ratchet
CC       that moves the RNA-DNA hybrid through the active site by switching
CC       from straight to bent conformations at each step of nucleotide
CC       addition (By similarity). {ECO:0000250|UniProtKB:P10964}.
CC   -!- CATALYTIC ACTIVITY: Nucleoside triphosphate + RNA(n) = diphosphate
CC       + RNA(n+1).
CC   -!- SUBUNIT: Component of the RNA polymerase I (Pol I) complex
CC       consisting of at least 13 subunits (PubMed:16809778). Interacts
CC       with MYO1C (By similarity). Interacts with ERBB2
CC       (PubMed:21555369). Interacts with DDX11 (PubMed:26089203).
CC       {ECO:0000250|UniProtKB:O35134, ECO:0000269|PubMed:16809778,
CC       ECO:0000269|PubMed:21555369, ECO:0000269|PubMed:26089203}.
CC   -!- INTERACTION:
CC       P04626:ERBB2; NbExp=16; IntAct=EBI-359472, EBI-641062;
CC       Q9H9Y6:POLR1B; NbExp=3; IntAct=EBI-359472, EBI-355441;
CC       Q04864:REL; NbExp=3; IntAct=EBI-359472, EBI-307352;
CC       P15884:TCF4; NbExp=3; IntAct=EBI-359472, EBI-533224;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000250}.
CC   -!- DISEASE: Acrofacial dysostosis, Cincinnati type (AFDCIN)
CC       [MIM:616462]: A form of acrofacial dysostosis, a group of
CC       disorders which are characterized by malformation of the
CC       craniofacial skeleton and, in some patients, the limbs.
CC       {ECO:0000269|PubMed:25913037}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the RNA polymerase beta' chain family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC99959.1; Type=Frameshift; Positions=1114, 1469; Evidence={ECO:0000305};
CC       Sequence=AAD09356.1; Type=Frameshift; Positions=1114; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U33460; AAC99959.1; ALT_FRAME; mRNA.
DR   EMBL; AH007280; AAD09356.1; ALT_FRAME; Transcribed_RNA.
DR   EMBL; AK302458; BAH13716.1; -; mRNA.
DR   EMBL; CH471053; EAW99467.1; -; Genomic_DNA.
DR   EMBL; CH471053; EAW99469.1; -; Genomic_DNA.
DR   EMBL; BC117173; AAI17174.1; -; mRNA.
DR   EMBL; BC126303; AAI26304.1; -; mRNA.
DR   EMBL; AL117467; CAB55942.1; -; mRNA.
DR   CCDS; CCDS42706.1; -.
DR   PIR; T17252; T17252.
DR   RefSeq; NP_056240.2; NM_015425.4.
DR   UniGene; Hs.531818; -.
DR   ProteinModelPortal; O95602; -.
DR   SMR; O95602; -.
DR   BioGrid; 117396; 81.
DR   DIP; DIP-27537N; -.
DR   IntAct; O95602; 51.
DR   MINT; MINT-111492; -.
DR   STRING; 9606.ENSP00000263857; -.
DR   BindingDB; O95602; -.
DR   ChEMBL; CHEMBL3286067; -.
DR   iPTMnet; O95602; -.
DR   PhosphoSitePlus; O95602; -.
DR   SwissPalm; O95602; -.
DR   BioMuta; POLR1A; -.
DR   SWISS-2DPAGE; O95602; -.
DR   EPD; O95602; -.
DR   MaxQB; O95602; -.
DR   PaxDb; O95602; -.
DR   PeptideAtlas; O95602; -.
DR   PRIDE; O95602; -.
DR   Ensembl; ENST00000263857; ENSP00000263857; ENSG00000068654.
DR   GeneID; 25885; -.
DR   KEGG; hsa:25885; -.
DR   UCSC; uc002sqs.4; human.
DR   CTD; 25885; -.
DR   DisGeNET; 25885; -.
DR   GeneCards; POLR1A; -.
DR   H-InvDB; HIX0002233; -.
DR   HGNC; HGNC:17264; POLR1A.
DR   HPA; CAB010145; -.
DR   HPA; HPA031513; -.
DR   HPA; HPA049700; -.
DR   MalaCards; POLR1A; -.
DR   MIM; 616404; gene.
DR   MIM; 616462; phenotype.
DR   neXtProt; NX_O95602; -.
DR   OpenTargets; ENSG00000068654; -.
DR   PharmGKB; PA134891380; -.
DR   eggNOG; KOG0262; Eukaryota.
DR   eggNOG; COG0086; LUCA.
DR   GeneTree; ENSGT00550000074861; -.
DR   HOGENOM; HOG000205401; -.
DR   HOVERGEN; HBG017741; -.
DR   InParanoid; O95602; -.
DR   KO; K02999; -.
DR   OMA; AMGAPKP; -.
DR   OrthoDB; EOG091G00IM; -.
DR   PhylomeDB; O95602; -.
DR   TreeFam; TF103033; -.
DR   Reactome; R-HSA-427413; NoRC negatively regulates rRNA expression.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-73762; RNA Polymerase I Transcription Initiation.
DR   Reactome; R-HSA-73772; RNA Polymerase I Promoter Escape.
DR   Reactome; R-HSA-73777; RNA Polymerase I Chain Elongation.
DR   Reactome; R-HSA-73863; RNA Polymerase I Transcription Termination.
DR   ChiTaRS; POLR1A; human.
DR   GeneWiki; POLR1A; -.
DR   GenomeRNAi; 25885; -.
DR   PMAP-CutDB; O95602; -.
DR   PRO; PR:O95602; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000068654; -.
DR   CleanEx; HS_POLR1A; -.
DR   ExpressionAtlas; O95602; baseline and differential.
DR   Genevisible; O95602; HS.
DR   GO; GO:0005736; C:DNA-directed RNA polymerase I complex; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0001054; F:RNA polymerase I activity; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:1904750; P:negative regulation of protein localization to nucleolus; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0045815; P:positive regulation of gene expression, epigenetic; TAS:Reactome.
DR   GO; GO:0006363; P:termination of RNA polymerase I transcription; TAS:Reactome.
DR   GO; GO:0006362; P:transcription elongation from RNA polymerase I promoter; TAS:Reactome.
DR   GO; GO:0006361; P:transcription initiation from RNA polymerase I promoter; TAS:Reactome.
DR   InterPro; IPR015699; DNA-dir_RNA_pol1_lsu.
DR   InterPro; IPR000722; RNA_pol_asu.
DR   InterPro; IPR006592; RNA_pol_N.
DR   InterPro; IPR007080; RNA_pol_Rpb1_1.
DR   InterPro; IPR007066; RNA_pol_Rpb1_3.
DR   InterPro; IPR007083; RNA_pol_Rpb1_4.
DR   InterPro; IPR007081; RNA_pol_Rpb1_5.
DR   PANTHER; PTHR19376:SF44; PTHR19376:SF44; 1.
DR   Pfam; PF04997; RNA_pol_Rpb1_1; 1.
DR   Pfam; PF00623; RNA_pol_Rpb1_2; 1.
DR   Pfam; PF04983; RNA_pol_Rpb1_3; 1.
DR   Pfam; PF05000; RNA_pol_Rpb1_4; 1.
DR   Pfam; PF04998; RNA_pol_Rpb1_5; 1.
DR   SMART; SM00663; RPOLA_N; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Disease mutation; DNA-directed RNA polymerase;
KW   Magnesium; Metal-binding; Nucleotidyltransferase; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transcription;
KW   Transferase; Zinc.
FT   CHAIN         1   1720       DNA-directed RNA polymerase I subunit
FT                                RPA1.
FT                                /FTId=PRO_0000073923.
FT   REGION      961    973       Bridging helix. {ECO:0000250}.
FT   METAL        64     64       Zinc. {ECO:0000250}.
FT   METAL        67     67       Zinc. {ECO:0000250}.
FT   METAL        74     74       Zinc. {ECO:0000250}.
FT   METAL        77     77       Zinc. {ECO:0000250}.
FT   METAL       588    588       Magnesium; catalytic. {ECO:0000250}.
FT   METAL       590    590       Magnesium; catalytic. {ECO:0000250}.
FT   METAL       592    592       Magnesium; catalytic. {ECO:0000250}.
FT   MOD_RES     240    240       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1386   1386       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   VARIANT     150    150       P -> A (in dbSNP:rs4832242).
FT                                {ECO:0000269|Ref.1, ECO:0000269|Ref.3}.
FT                                /FTId=VAR_047493.
FT   VARIANT     349    349       Q -> E (in dbSNP:rs17026866).
FT                                /FTId=VAR_047494.
FT   VARIANT     364    364       K -> E (in dbSNP:rs35239368).
FT                                /FTId=VAR_047495.
FT   VARIANT     396    396       S -> N (in dbSNP:rs35443467).
FT                                /FTId=VAR_047496.
FT   VARIANT     593    593       E -> Q (in AFDCIN; dbSNP:rs794729674).
FT                                {ECO:0000269|PubMed:25913037}.
FT                                /FTId=VAR_073964.
FT   VARIANT     815    815       I -> V (in dbSNP:rs34302587).
FT                                /FTId=VAR_047497.
FT   VARIANT    1141   1141       A -> T (in dbSNP:rs34892520).
FT                                /FTId=VAR_047498.
FT   VARIANT    1299   1299       V -> F (in AFDCIN).
FT                                {ECO:0000269|PubMed:25913037}.
FT                                /FTId=VAR_073965.
FT   VARIANT    1608   1608       I -> M (in dbSNP:rs35093541).
FT                                /FTId=VAR_047499.
FT   CONFLICT    143    143       N -> S (in Ref. 1; AAC99959).
FT                                {ECO:0000305}.
FT   CONFLICT    309    309       Y -> S (in Ref. 1; AAC99959).
FT                                {ECO:0000305}.
FT   CONFLICT    411    411       M -> R (in Ref. 1; AAC99959).
FT                                {ECO:0000305}.
FT   CONFLICT    439    440       YA -> ST (in Ref. 1; AAC99959).
FT                                {ECO:0000305}.
FT   CONFLICT    808    808       A -> R (in Ref. 1; AAC99959).
FT                                {ECO:0000305}.
FT   CONFLICT    893    893       S -> T (in Ref. 1; AAC99959).
FT                                {ECO:0000305}.
FT   CONFLICT    896    896       M -> L (in Ref. 1; AAC99959).
FT                                {ECO:0000305}.
FT   CONFLICT    925    926       RP -> ST (in Ref. 1; AAC99959).
FT                                {ECO:0000305}.
FT   CONFLICT    986    986       G -> A (in Ref. 1; AAD09356).
FT                                {ECO:0000305}.
FT   CONFLICT   1371   1373       RAT -> TRI (in Ref. 1; AAD09356).
FT                                {ECO:0000305}.
FT   CONFLICT   1470   1471       Missing (in Ref. 1; AAC99959).
FT                                {ECO:0000305}.
FT   CONFLICT   1616   1616       Missing (in Ref. 1; AAC99959).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1720 AA;  194811 MW;  AD4BA543FFB98DC6 CRC64;
     MLISKNMPWR RLQGISFGMY SAEELKKLSV KSITNPRYLD SLGNPSANGL YDLALGPADS
     KEVCSTCVQD FSNCSGHLGH IELPLTVYNP LLFDKLYLLL RGSCLNCHML TCPRAVIHLL
     LCQLRVLEVG ALQAVYELER ILNRFLEENP DPSASEIREE LEQYTTEIVQ NNLLGSQGAH
     VKNVCESKSK LIALFWKAHM NAKRCPHCKT GRSVVRKEHN SKLTITFPAM VHRTAGQKDS
     EPLGIEEAQI GKRGYLTPTS AREHLSALWK NEGFFLNYLF SGMDDDGMES RFNPSVFFLD
     FLVVPPSRYR PVSRLGDQMF TNGQTVNLQA VMKDVVLIRK LLALMAQEQK LPEEVATPTT
     DEEKDSLIAI DRSFLSTLPG QSLIDKLYNI WIRLQSHVNI VFDSEMDKLM MDKYPGIRQI
     LEKKEGLFRK HMMGKRVDYA ARSVICPDMY INTNEIGIPM VFATKLTYPQ PVTPWNVQEL
     RQAVINGPNV HPGASMVINE DGSRTALSAV DMTQREAVAK QLLTPATGAP KPQGTKIVCR
     HVKNGDILLL NRQPTLHRPS IQAHRARILP EEKVLRLHYA NCKAYNADFD GDEMNAHFPQ
     SELGRAEAYV LACTDQQYLV PKDGQPLAGL IQDHMVSGAS MTTRGCFFTR EHYMELVYRG
     LTDKVGRVKL LSPSILKPFP LWTGKQVVST LLINIIPEDH IPLNLSGKAK ITGKAWVKET
     PRSVPGFNPD SMCESQVIIR EGELLCGVLD KAHYGSSAYG LVHCCYEIYG GETSGKVLTC
     LARLFTAYLQ LYRGFTLGVE DILVKPKADV KRQRIIEEST HCGPQAVRAA LNLPEAASYD
     EVRGKWQDAH LGKDQRDFNM IDLKFKEEVN HYSNEINKAC MPFGLHRQFP ENSLQMMVQS
     GAKGSTVNTM QISCLLGQIE LEGRRPPLMA SGKSLPCFEP YEFTPRAGGF VTGRFLTGIK
     PPEFFFHCMA GREGLVDTAV KTSRSGYLQR CIIKHLEGLV VQYDLTVRDS DGSVVQFLYG
     EDGLDIPKTQ FLQPKQFPFL ASNYEVIMKS QHLHEVLSRA DPKKALHHFR AIKKWQSKHP
     NTLLRRGAFL SYSQKIQEAV KALKLESENR NGRSPGTQEM LRMWYELDEE SRRKYQKKAA
     ACPDPSLSVW RPDIYFASVS ETFETKVDDY SQEWAAQTEK SYEKSELSLD RLRTLLQLKW
     QRSLCEPGEA VGLLAAQSIG EPSTQMTLNT FHFAGRGEMN VTLGIPRLRE ILMVASANIK
     TPMMSVPVLN TKKALKRVKS LKKQLTRVCL GEVLQKIDVQ ESFCMEEKQN KFQVYQLRFQ
     FLPHAYYQQE KCLRPEDILR FMETRFFKLL MESIKKKNNK ASAFRNVNTR RATQRDLDNA
     GELGRSRGEQ EGDEEEEGHI VDAEAEEGDA DASDAKRKEK QEEEVDYESE EEEEREGEEN
     DDEDMQEERN PHREGARKTQ EQDEEVGLGT EEDPSLPALL TQPRKPTHSQ EPQGPEAMER
     RVQAVREIHP FIDDYQYDTE ESLWCQVTVK LPLMKINFDM SSLVVSLAHG AVIYATKGIT
     RCLLNETTNN KNEKELVLNT EGINLPELFK YAEVLDLRRL YSNDIHAIAN TYGIEAALRV
     IEKEIKDVFA VYGIAVDPRH LSLVADYMCF EGVYKPLNRF GIRSNSSPLQ QMTFETSFQF
     LKQATMLGSH DELRSPSACL VVGKVVRGGT GLFELKQPLR
//
